Interestingly, H3K36Me3 has not yet been extensively studied in NHL patients but an accumulation of this mark mediated by SETD2 or NSD2 has been associated with progression of acute myeloid leukemia48,49. This evidence concerns the gene NSD2 and non-Hodgkin lymphoma.